Cardiotrophin-1 attenuates experimental colitis in mice.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Clinical science

• Publication date

  2018-05-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1042/CS20171513PMID 29572384
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting IKK and NF-κB for Therapy.

  2017cited by this paper
• The Changing Landscape of Inflammatory Bowel Disease: East Meets West.

  2016cited by this paper
• Cardiotrophin-1: A multifaceted cytokine.

  2015cited by this paper
• Cardiotrophin-1 decreases liver apoptosis through calpastatin induction.

  2015cited by this paper
• Interleukin-10 gene-carrying bifidobacteria ameliorate murine ulcerative colitis by regulating regulatory T cell/T helper 17 cell pathway

  2015cited by this paper
• Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease

  2015cited by this paper
• The global burden of IBD: from 2015 to 2025

  2015cited by this paper
• Cardiotrophin-1 administration prevents the renal toxicity of iodinated contrast media in rats.

  2013cited by this paper
• Cardiotrophin-1 reduces ischemia/reperfusion injury during liver transplant.

  2013cited by this paper
• Cardiotrophin 1 protects beta cells from apoptosis and prevents streptozotocin-induced diabetes in a mouse model

  2013cited by this paper
• Cardiotrophin-1 Administration Protects from Ischemia-Reperfusion Renal Injury and Inflammation

  2013cited by this paper
• The burden of inflammatory bowel disease in Europe.

  2013cited by this paper
• Central Role of the Gut Epithelial Barrier in the Pathogenesis of Chronic Intestinal Inflammation: Lessons Learned from Animal Models and Human Genetics

  2013cited by this paper
• Effects and mechanism of organ protection by cardiotrophin-1.

  2012cited by this paper
• Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study

  2012cited by this paper
• Ulcerative colitis as a progressive disease: the forgotten evidence.

  2012cited by this paper
• Cardiotrophin 1 Is Involved in Cardiac, Vascular, and Renal Fibrosis and Dysfunction

  2012cited by this paper
• Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.

  2012cited by this paper
• Cardiotrophin-1 Promotes a High Survival Rate in Rabbits with Lethal Fulminant Hepatitis of Viral Origin

  2011cited by this paper
• Role of NF-kappaB activation in intestinal immune homeostasis.

  2010cited by this paper
• Deletion of H-Ras decreases renal fibrosis and myofibroblast activation following ureteral obstruction in mice.

  2010cited by this paper
• Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway.

  2010cited by this paper
• The resolution of inflammation: anti-inflammatory roles for NF-kappaB.

  2010cited by this paper
• Caspase inhibition by cardiotrophin‐1 prevents neuronal death in vivo and in vitro

  2009cited by this paper
• Nuclear factor-kappa B in intestinal protection and destruction

  2009cited by this paper
• The nuclear factor NF-kappaB pathway in inflammation.

  2009cited by this paper
• Burden of digestive diseases in the United States part II: lower gastrointestinal diseases.

  2009cited by this paper
• Diversity in the contribution of interleukin‐10 to T‐cell‐mediated immune regulation

  2008cited by this paper
• Role of STAT3 in inflammatory bowel disease.

  2008cited by this paper
• Unravelling the pathogenesis of inflammatory bowel disease

  2007cited by this paper
• Cardioprotective role of cardiotrophin-1 gene transfer in a murine model of myocardial infarction

  2007cited by this paper
• Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000

  2007cited by this paper
• Chemically induced mouse models of intestinal inflammation

  2007cited by this paper
• Cardiotrophin‐1 is an essential factor in the natural defense of the liver against apoptosis

  2007cited by this paper
• Disrupted Barrier Function through Epithelial Cell Apoptosis

  2006cited by this paper
• Bacterial translocation as a source of Dacron-graft contamination in experimental aortic operation: the importance of controlling SIRS.

  2006cited by this paper
• Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning

  2006cited by this paper
• Signal Transducers and Activators of Transcription 3 Signaling Pathway: An Essential Mediator of Inflammatory Bowel Disease and Other Forms of Intestinal Inflammation

  2005cited by this paper
• Activation of nuclear factor κB in colonic mucosa from patients with collagenous and ulcerative colitis

  2005cited by this paper
• Activation Pattern of Signal Transducers and Activators of Transcription (STAT) Factors in Inflammatory Bowel Diseases

  2005cited by this paper
• Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis.

  2005cited by this paper
• Characterization of the protective effects of cardiotrophin-1 against non-ischemic death stimuli in adult cardiomyocytes.

  2005cited by this paper
• Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis.

  2004cited by this paper
• Protection against liver damage by cardiotrophin-1: a hepatocyte survival factor up-regulated in the regenerating liver in rats.

  2003cited by this paper
• STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: A critical role of STAT3 in innate immunity

  2003cited by this paper
• Increased Enterocyte Apoptosis in Inflamed Areas of Crohn’s Disease

  2003cited by this paper
• Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischaemia and at reperfusion.

  2002cited by this paper
• Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice

  2002cited by this paper
• Collagen-binding integrin alpha1beta1 regulates intestinal inflammation in experimental colitis.

  2002cited by this paper
• Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation.

  2002cited by this paper
• Collagen-binding integrin α1β1 regulates intestinal inflammation in experimental colitis

  2002cited by this paper
• Increase in colorectal epithelial apoptotic cells in patients with ulcerative colitis ultimately requiring surgery

  2002cited by this paper
• Interleukin-10 and the interleukin-10 receptor.

  2001cited by this paper
• Cis3/Socs3/Ssi3 Plays a Negative Regulatory Role in Stat3 Activation and Intestinal Inflammation

  2001cited by this paper
• Cytokines promote motoneuron survival through the Janus kinase-dependent activation of the phosphatidylinositol 3-kinase pathway.

  2001cited by this paper
• Regulation of Murine Intestinal Inflammation by Reactive Metabolites of Oxygen and Nitrogen

  2001cited by this paper
• Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation.

  2001cited by this paper
• Possible new role for NF-kappaB in the resolution of inflammation.

  2001cited by this paper
• Possible new role for NF-κB in the resolution of inflammation

  2001cited by this paper
• Cardiotrophin-1: a novel cytokine and its effects in the heart and other tissues.

  2000cited by this paper
• Negative regulation of cytokine signaling pathways.

  2000cited by this paper
• In vitro and in vivo effects of gliotoxin, a fungal metabolite: efficacy against dextran sodium sulfate-induced colitis in rats.

  2000cited by this paper
• Interleukin 10 gene transfer prevents experimental colitis in rats

  2000cited by this paper
• Bax is downregulated in inflamed colonic mucosa of ulcerative colitis

  2000cited by this paper
• In Vitro and In Vivo Effects of Gliotoxin, a Fungal Metabolite:

  2000cited by this paper
• Cytokine-Induced Nuclear Factor Kappa B Activation Promotes the Survival of Developing Neurons

  2000cited by this paper
• p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system.

  2000cited by this paper
• Roles of STAT3 defined by tissue-specific gene targeting

  2000cited by this paper
• Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo

  2000cited by this paper
• Cardiotrophin-1 attenuates endotoxin-induced acute lung injury.

  1999cited by this paper
• Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils.

  1999cited by this paper
• Control of apoptosis by Rel/NF-κB transcription factors

  1999cited by this paper
• Control of apoptosis by Rel/NF-kappaB transcription factors.

  1999cited by this paper
• Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli.

  1998cited by this paper
• The Pathogenesis of Mucosal Inflammation in Murine Models of Inflammatory Bowel Disease and Crohn Disease

  1998cited by this paper
• Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa.

  1998cited by this paper
• Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines

  1998cited by this paper
• Cardiotrophin-1 inhibits tumor necrosis factor production in the heart and serum of lipopolysaccharide-treated mice and in vitro in mouse blood cells.

  1996cited by this paper
• Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor-gp 130 dependent pathways.

  1996cited by this paper
• Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.

  1996cited by this paper
• Immunosuppressive and anti-inflammatory properties of interleukin 10.

  1995cited by this paper
• Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors

  1995cited by this paper
• Cardiotrophin-1

  1995cited by this paper
• Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice.

  1993cited by this paper
• A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.

  1990cited by this paper
• A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice

  1990cited by this paper
• Tumour necrosis factor‐alpha and interferon‐gamma production measured at the single cell level in normal and inflamed human intestine

  1990cited by this paper
• Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

  1989cited by this paper
• lnterleukin-10-Deficient Mice Develop Chronic Enterocolitis

  year unknowncited by this paper

• Engineered living materials: emerging frontiers in therapeutic innovation and management of skin disorders

  2025cites this paper
• Cytokines of the interleukin-6 family as emerging targets in inflammatory bowel disease

  2024cites this paper
• Isobutyrate exerts a protective effect against liver injury in a DSS-induced colitis by inhibiting inflammation and oxidative stress.

  2024cites this paper
• New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology

  2021cites this paper
• Effect of vitexin on alleviating liver inflammation in a dextran sulfate sodium (DSS)-induced colitis model.

  2020cites this paper
• Preventive Effect of Cardiotrophin-1 Administration before DSS-Induced Ulcerative Colitis in Mice

  2019influential citation
• Potential clinical treatment of colitis with cardiotrophin-1.

  2018cites this paper